Protocol for diversion of a CD4+ response to the T-helper 2 cell pathway.
Galbiati
F
F
Roche Milano Ricerche, Italy.
Adorini
L
L
D000818:Animals; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000276:immunology; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D002454:Cell Differentiation; D005434:Flow Cytometry / Q000379:methods; D007371:Interferon-gamma / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D016773:Leishmaniasis, Cutaneous / Q000276:immunology; D008285:Major Histocompatibility Complex; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D009113:Muramidase / Q000276:immunology; D011110:Polymorphism, Genetic; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology*
D000941:Antigens; D015847:Interleukin-4; D007371:Interferon-gamma; D009113:Muramidase